In another study, the therapeutic potential of small EVs obtained from human amniotic mesenchymal stem cells (hAMSCs) engineered to overexpress Nrf2 was explored, aiming to protect against LPS-induced ALI in mice. Here, NFE2L2 is linked to acute respiratory distress syndrome.